Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration
Access to Parkinson's disease medicines in Kenya is limited, with severe implications for symptom management and quality of life. People with Parkinson's disease should be able to access and afford the medicines they need to manage their condition.
Authors
- Judith Kwasa (ORCID: https://orcid.org/0000-0001-7110-3902)
- Natasha Fothergill‐Misbah (ORCID: https://orcid.org/0000-0002-1192-6250)
- Juzar Hooker (ORCID: https://orcid.org/0000-0001-7057-1843)
- Richard Walker
Institutions
- University of Nairobi (KE)
- Aga Khan University Hospital Nairobi (KE)
- Northumbria Healthcare NHS Foundation Trust (GB)
- Aga Khan University Nairobi (KE)
- Newcastle University (GB)
Publication Details
- Journal
- Movement Disorders Clinical Practice
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1002/mdc3.14192
- Citations
- 3
- Primary Topic
- Papaya Research and Applications
- Type
- article
- Field-Weighted Citation Impact
- 2.15
Funders
- Economic and Social Research Council